Patents by Inventor David Fenard

David Fenard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigen Binders Specific For IL-23R And Uses Thereof
    Publication number: 20260027152
    Abstract: IL23R overexpression has been described as a common feature of pathogenic inflammatory cells involved in the onset and maintenance of autoimmune diseases and chronic inflammation. The present disclosure relates to a novel antigen binder directed to IL-23R, to compositions that comprise said antigen binder, and to the use of said antigen binder. The present disclosure further relates to fusion proteins comprising said antigen binder, such as, for example, chimeric antigen receptors.
    Type: Application
    Filed: June 24, 2022
    Publication date: January 29, 2026
    Applicant: Sangamo Therapeutics, Inc.
    Inventors: Tobias ABEL, Maurus DE LA ROSA, David FENARD, Julie GERTNER-DARDENNE
  • COMPOSITIONS AND METHODS FOR IMPROVING VIRAL VECTOR EFFICIENCY
    Publication number: 20230117384
    Abstract: The present invention relates to peptides and compositions for use in improving transduction efficiency of viruses into target cells.
    Type: Application
    Filed: May 23, 2022
    Publication date: April 20, 2023
    Inventors: Saliha MAJDOUL, David FENARD
  • Compositions and methods for improving viral vector efficiency
    Patent number: 11371061
    Abstract: The present invention relates to peptides and compositions for use in improving transduction efficiency of viruses into target cells.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: June 28, 2022
    Assignees: GENETHON, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE D'EVRY VAL D'ESSONNE
    Inventors: Saliha Majdoul, David Fenard
  • NEW CAR CONSTRUCTS COMPRISING TNFR2 DOMAINS
    Publication number: 20210292389
    Abstract: The present invention relates to a chimeric antigen receptor (CAR) comprising a human TNFR2 transmembrane domain (TM) or a fragment or variant thereof and/or a human TNFR2 costimulatory intracellular signaling domain or a fragment or variant thereof, and to an immune cell expressing said CAR. The present invention further relates to therapeutic methods comprising the administration of an immune cell expressing a chimeric antigen receptor (CAR) comprising a human TNFR2 transmembrane domain (TM) or a fragment or variant thereof and/or a human TNFR2 costimulatory intracellular signaling domain or a fragment or variant thereof.
    Type: Application
    Filed: August 9, 2019
    Publication date: September 23, 2021
    Applicant: SANGAMO THERAPEUTICS FRANCE
    Inventors: Tobias Abel, David Fenard, Julie Gertner-Dardenne, François Meyer
  • Peptides with viral infection enhancing properties and their use
    Patent number: 10596264
    Abstract: The invention relates to LAH4 peptides and functional derivatives thereof and their use for improving transduction efficiency of viruses into target cells.
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: March 24, 2020
    Assignees: Genethon, Centre National de la Recherche Scientique, Institut National de la Sainte et de la Recherche Madicale
    Inventors: David Fenard, Antoine Kichler, Samia Martin
  • Method for purifying enveloped viruses or viral vectors
    Patent number: 10465169
    Abstract: The invention relates to a process for purifying enveloped viruses. The process of the invention is useful for recovering at a large scale enveloped viruses under conditions complying with good manufacturing practices and allowing viruses of a clinical grade to be obtained.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: November 5, 2019
    Assignee: GENETHON
    Inventors: Driss Boudeffa, Otto-Wilhelm Merten, David Fenard
  • Method for producing enveloped viruses
    Patent number: 10125352
    Abstract: The invention relates to a process for producing enveloped viruses in a mildly acid medium. The processes of the invention are useful for producing and recovering at a large scale enveloped viruses under conditions observing good manufacturing practice (GMP).
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: November 13, 2018
    Assignee: GENETHON
    Inventor: David Fenard
  • COMPOSITIONS AND METHODS FOR IMPROVING VIRAL VECTOR EFFICIENCY
    Publication number: 20180318447
    Abstract: The present invention relates to peptides and compositions for use in improving transduction efficiency of viruses into target cells.
    Type: Application
    Filed: November 30, 2016
    Publication date: November 8, 2018
    Inventors: Saliha MAJDOUL, David FENARD
  • METHOD FOR PURIFYING ENVELOPED VIRUSES OR VIRAL VECTORS
    Publication number: 20170002332
    Abstract: The invention relates to a process for purifying enveloped viruses. The process of the invention is useful for recovering at a large scale enveloped viruses under conditions complying with good manufacturing practices and allowing viruses of a clinical grade to be obtained.
    Type: Application
    Filed: December 17, 2014
    Publication date: January 5, 2017
    Inventors: DRISS BOUDEFFA, OTTO-WILHELM MERTEN, DAVID FENARD
  • METHOD FOR PRODUCING ENVELOPED VIRUSES
    Publication number: 20160230147
    Abstract: The invention relates to a process for producing enveloped viruses in a mildly acid medium. The processes of the invention are useful for producing and recovering at a large scale enveloped viruses under conditions observing good manufacturing practices (or GMP).
    Type: Application
    Filed: September 12, 2014
    Publication date: August 11, 2016
    Applicant: GENETHON
    Inventor: DAVID FENARD
  • PEPTIDES WITH VIRAL INFECTION ENHANCING PROPERTIES AND THEIR USE
    Publication number: 20140255349
    Abstract: The invention relates to peptides and functional derivatives thereof and their use for improving transduction efficiency of viruses into target cells.
    Type: Application
    Filed: June 28, 2012
    Publication date: September 11, 2014
    Applicants: GENETHON, Institut National de la Sainte et de la recherche Madicale, Centre National de la Recherche Scientique
    Inventors: David Fenard, Antoine Kichler, Samia Martin